- Home
- CRMD vs RNP Comparison
CRMD vs RNP Comparison
Compare CRMD & RNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRMD | RNP |
|---|---|---|
| Founded | 2006 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 876.7M | 996.9M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | CRMD | RNP |
|---|---|---|
| Price | $10.28 | $20.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $17.43 | N/A |
| AVG Volume (30 Days) | ★ 3.0M | 117.6K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.94% |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.25 | N/A |
| Revenue | ★ $214,303,672.00 | N/A |
| Revenue This Year | $565.64 | N/A |
| Revenue Next Year | $46.09 | N/A |
| P/E Ratio | $4.58 | ★ N/A |
| Revenue Growth | ★ 1647.67 | N/A |
| 52 Week Low | $5.60 | $15.52 |
| 52 Week High | $17.43 | $21.27 |
Technical Indicators
Market Signals| Indicator | CRMD | RNP |
|---|---|---|
| Relative Strength Index (RSI) | 48.12 | 43.55 |
| Support Level | $9.20 | $20.17 |
| Resistance Level | $9.88 | $20.84 |
| Average True Range (ATR) | 0.56 | 0.29 |
| MACD | 0.00 | 0.06 |
| Stochastic Oscillator | 39.33 | 54.13 |
Price Performance
Historical ComparisonAbout CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
About RNP Cohen & Steers REIT and Preferred and Income Fund Inc.
Cohen & Steers REIT and Preferred Income Fund Inc is a diversified, closed-ended investment management fund. Its investment objective is to provide high current income with capital appreciation as its secondary objective. The Fund invests at least its total assets in common stocks issued by real estate investment trusts (REITs) and preferred securities under normal circumstances.